However, RON and MET expression was not associated with patient age at tumorectomy (<65 vs. ≥65 years), gender, lymph node metastasis, tumor-node-metastasis (TNM) stage, or chemotherapy treatment. The gene discussed is MET; the disease is neoplasm.